essence study semaglutide (#wegovy/#ozempic) has better results, thus far, in its phase 3 fatty liver trial than its previous phase 2 trial it seems. 72-week data presented at The Liver Meeting 2024: American Association ESSENCE - Semaglutide in Metabolic

Introduction Given the global increase in obesity prevalence, there has been an emergence of a multitude of treatment options, specifically less invasive operations, like intragastric balloons, and pharmaceutical treatments like semaglutide

So, while we should always be grateful for scientific breakthroughs that ease care, we should also recognize that its the clinicians, new technology, and new care models that ultimately determine whether innovation leaves a lasting impact.

That combination has contributed to (1) expanding personalinjury allegations against manufacturers, (2) ongoing scrutiny of compounded alternatives, and (3) increased attention to promotional practices, including directtoconsumer advertising and influencer marketing

This advanced treatment helps achieve significant weight loss and maintain a healthier weight long-term, providing a sustainable path to lasting health transformation for those struggling with weight issues.

Clinical trials show that reducing body weight often leads to a drop in apnea-hypopnea index (AHI), which measures breathing interruptions during sleep

A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users